Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

F18-fluoromethylcholine (FCho), F18-fluoroethyltyrosine (FET) and F18-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma (HGG) and radiation necrosis (RN): A μPET study

Julie Bolcaen, Benedicte Descamps, Karel Deblaere, Tom Boterberg, Filip De Vos, Jean-Pierre Kalala Okito, Caroline Van den Broecke, Christian Vanhove and Ingeborg Goethals
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1379;
Julie Bolcaen
2Ghent University, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benedicte Descamps
2Ghent University, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karel Deblaere
1University Hospital, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Boterberg
1University Hospital, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Filip De Vos
2Ghent University, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Pierre Kalala Okito
1University Hospital, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Van den Broecke
1University Hospital, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Vanhove
2Ghent University, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingeborg Goethals
1University Hospital, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1379

Objectives Discrimination between HGG and RN remains a diagnostic challenge because both entities have similar imaging characteristics on conventional MRI. Metabolic imaging, such as PET could aid in this diagnostic dilemma. In this study, we investigated the potential of F18-FDG, F18-FCho and F18-FET PET in discriminating HGG from RN.

Methods On day 15 after inoculation of F98 glioblastoma (GB) cells in the rat brain, MRI showed a contrast-enhancing tumor. μPET was performed (dynamic F18-FDG PET at conventional intervals followed by a delayed (240 min p.i.) acquisition, dynamic F18-FCho and F18-FET PET, n=4). Induction of RN was achieved by irradiating the right frontal region with 60 Gy using 3 arcs of 3*3mm. Follow-up MRI scans revealed a contrast-enhancing RN lesion 6-7 months post-irradiation and μPET was performed (n=3). The time activity curves (TACs) of the mean standard uptake value (SUV) and the lesion-to-normal tissue uptake ratio (LNR) measured during the last time frame were compared between GB and RN (see figure).

Results On conventional F18-FDG PET, mean LNR in GB (1.35±0.08) was higher compared to RN (1.04±0.08) and were significantly different (p=0.034). The difference in LNR was higher on the delayed F18-FDG scan (1.60±0.25 in GB and 1.06±0.01 in RN), however borderline significant (p=0.064) due to the small sample size (n=2). For F18-FCho, LNRs in GB and RN were 2.55±0.39 and 2.45±0.16, respectively and not significanlty different (p=1.000), meaning that 18F-FCho cannot discriminate between GB and RN. F18-FET uptake was higher in GB with a LNR of 2.19±0.16, while a LNR of 1.71±0.32 was shown in RN. F18-FET LNRs were significantly higher in GB than in RN (p=0.034).

Conclusions Based on these results, F18-FDG and F18-FET PET were able to discriminate GB from RN whereas F18-FCho was not. However, because there was visible uptake of F18-FET in RN (not shown) , a threshold will be necessary.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
F18-fluoromethylcholine (FCho), F18-fluoroethyltyrosine (FET) and F18-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma (HGG) and radiation necrosis (RN): A μPET study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
F18-fluoromethylcholine (FCho), F18-fluoroethyltyrosine (FET) and F18-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma (HGG) and radiation necrosis (RN): A μPET study
Julie Bolcaen, Benedicte Descamps, Karel Deblaere, Tom Boterberg, Filip De Vos, Jean-Pierre Kalala Okito, Caroline Van den Broecke, Christian Vanhove, Ingeborg Goethals
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1379;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
F18-fluoromethylcholine (FCho), F18-fluoroethyltyrosine (FET) and F18-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma (HGG) and radiation necrosis (RN): A μPET study
Julie Bolcaen, Benedicte Descamps, Karel Deblaere, Tom Boterberg, Filip De Vos, Jean-Pierre Kalala Okito, Caroline Van den Broecke, Christian Vanhove, Ingeborg Goethals
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1379;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Comparison of in vivo uptake of radioactive gold nanoparticles formulated using phytochemicals
  • Ac-225-DOTATOC - an empiric dose finding for alpha particle emitter based radionuclide therapy of neuroendocrine tumors
  • I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer
Show more Oncology: Basic, Translational & Therapy

MTA I: Oncology Basic, Basic Science Posters

  • Evaluation of tumor targeting efficacy of 67Ga-labeled bombesin peptide functionalized gold nanoparticle in mice model
  • Multiple myeloma imaging by C-11-acetate metabolic PET and in vitro metabolite fate mapping using isotope-edited NMR
  • Preclinical assessment of a BB2r biomarker for use in breast cancer
Show more MTA I: Oncology Basic, Basic Science Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire